Roundview Capital LLC reduced its position in Proto Labs, Inc. (NYSE:PRLB) by 4.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,335 shares of the company’s stock after selling 270 shares during the period. Roundview Capital LLC’s holdings in Proto Labs were worth $274,000 as of its most recent filing with the SEC.

Other institutional investors have also recently modified their holdings of the company. Trent Capital Management Inc. NC bought a new stake in Proto Labs during the fourth quarter valued at $119,000. Perigon Wealth Management LLC bought a new stake in Proto Labs during the second quarter valued at $174,000. Advisor Group Inc. increased its stake in Proto Labs by 3.8% in the third quarter. Advisor Group Inc. now owns 3,075 shares of the company’s stock valued at $184,000 after buying an additional 112 shares during the last quarter. Teacher Retirement System of Texas increased its stake in Proto Labs by 17.6% in the second quarter. Teacher Retirement System of Texas now owns 3,391 shares of the company’s stock valued at $195,000 after buying an additional 507 shares during the last quarter. Finally, Aperio Group LLC bought a new stake in Proto Labs during the third quarter valued at $213,000.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Shares of Proto Labs, Inc. (NYSE:PRLB) traded down 1.85% during midday trading on Thursday, hitting $55.65. 243,025 shares of the company were exchanged. The stock has a market cap of $1.47 billion, a PE ratio of 34.57 and a beta of 0.71. Proto Labs, Inc. has a one year low of $43.10 and a one year high of $82.06. The stock’s 50-day moving average is $53.13 and its 200-day moving average is $54.07.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings results on Thursday, February 9th. The company reported $0.41 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.02. Proto Labs had a net margin of 14.33% and a return on equity of 11.79%. The company had revenue of $72.40 million for the quarter, compared to analyst estimates of $72.41 million. During the same quarter in the prior year, the business posted $0.50 EPS. Proto Labs’s quarterly revenue was down 1.9% on a year-over-year basis. Equities research analysts anticipate that Proto Labs, Inc. will post $1.96 EPS for the current year.

This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was stolen and reposted in violation of United States and international copyright law. The original version of this report can be read at http://www.watchlistnews.com/proto-labs-inc-prlb-stake-reduced-by-roundview-capital-llc/1121320.html.

PRLB has been the subject of several research analyst reports. Canaccord Genuity downgraded shares of Proto Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 28th. Zacks Investment Research downgraded shares of Proto Labs from a “hold” rating to a “sell” rating in a research report on Wednesday, November 2nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $70.25.

In other news, VP John B. Tumelty sold 862 shares of the stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $56.78, for a total transaction of $48,944.36. Following the transaction, the vice president now owns 17,057 shares in the company, valued at approximately $968,496.46. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Victoria M. Holt sold 2,025 shares of the stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $56.80, for a total transaction of $115,020.00. Following the transaction, the insider now owns 44,018 shares in the company, valued at approximately $2,500,222.40. The disclosure for this sale can be found here. Corporate insiders own 8.48% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc is an online and technology-enabled manufacturer of on-demand three-dimensional (3D)-printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. It utilizes injection molding, CNC machining and 3D printing to manufacture custom parts for its customers.

5 Day Chart for NYSE:PRLB

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB).

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.